CNVS.NASDAQCineverse CORP

Form 4: Cineverse CFO Reports Equity Holdings Update

Sentiment:

Insider Transaction Report


Cineverse CFO Mark Lindsey reports changes in beneficial ownership, including new restricted stock units and vesting schedules for existing equity awards.

Summary

  • Mark Wayne Lindsey, CFO of Cineverse Corp. (CNVS), reported changes in his beneficial ownership.
  • He directly owns 119,168 shares of Class A Common Stock, which includes 66,667 shares of restricted stock.
  • The restricted stock included in the common stock ownership vests in two tranches: 33,333 shares on April 25, 2026, and 33,334 shares on April 25, 2027.
  • Lindsey holds 20,000 Stock Appreciation Rights (SARs) with an exercise price of $11.95 and an expiration date of November 14, 2032.
  • The SARs vest in three tranches: 6,667 vested on November 14, 2023, 6,667 vested on November 14, 2024, and 6,666 vest on November 14, 2025.
  • He acquired 71,699 Restricted Stock Units (RSUs) on September 23, 2025.
  • These 71,699 RSUs vest in three tranches: 23,900 on September 23, 2026, 23,900 on September 23, 2027, and 23,899 on September 23, 2028.
  • Lindsey also holds 66,667 Restricted Stock Units (RSUs) for which the vesting schedule is detailed as 33,333 units on April 25, 2025, 33,333 units on April 25, 2026, and 33,334 units on April 25, 2027.

Sentiment

Score: 6

Explanation: The filing reports routine executive compensation in the form of equity awards, which generally aligns management's interests with shareholders. There are no immediate negative implications, and the long-term vesting schedules suggest stability in executive retention.

Positives

  • Increased equity ownership by a key executive (CFO) aligns his interests with shareholders.
  • The grant of new Restricted Stock Units (71,699 RSUs) and the vesting of existing awards demonstrate ongoing executive compensation and retention strategies.
  • Long-term incentives like SARs (expiring 2032) and multi-year vesting schedules encourage sustained performance.

Negatives

  • No immediate cash transaction or direct stock purchase by the insider, indicating compensation rather than open market buying.
  • The value of the equity awards is subject to future stock price performance, introducing market risk.

Risks

  • Market Price Volatility: The value of the Class A Common Stock, SARs, and RSUs is directly tied to the market price of Cineverse Corp. shares, which can fluctuate significantly.
  • Vesting Conditions: The full realization of the value from restricted stock and RSUs is contingent upon the reporting person's continued employment and the satisfaction of vesting schedules.
  • Dilution: Future exercises of SARs or vesting of RSUs could lead to a slight dilution of existing shareholder equity, although this is standard for equity compensation plans.

Future Outlook

The filing indicates a structured long-term incentive plan for the CFO, with significant portions of his equity compensation scheduled to vest over the next several years, specifically through September 2028 for RSUs and April 2027 for restricted stock, and SARs expiring in November 2032. This suggests a commitment to retaining key management and aligning their interests with long-term company performance.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transactions, specifically related to compensation. It does not provide information on broader industry trends or competitive positioning, but rather details the compensation structure for a key executive within Cineverse Corp.

Related Party Transactions

  • Grant of 71,699 Restricted Stock Units to Mark Wayne Lindsey, CFO, on September 23, 2025, as part of his compensation.
  • Ongoing vesting of 66,667 shares of restricted stock, 20,000 Stock Appreciation Rights, and 66,667 Restricted Stock Units to Mark Wayne Lindsey, CFO, as part of his compensation.

Stakeholder Impact

  • Shareholders: Increased alignment of the CFO's financial interests with long-term shareholder value creation due to significant equity holdings and multi-year vesting schedules.
  • Employees: Reflects the company's ongoing executive compensation strategy, which may influence broader compensation practices.
  • Management: The equity awards serve as a key component of the CFO's compensation and retention package, incentivizing performance.

Next Steps

  • Vesting of 6,666 Stock Appreciation Rights on November 14, 2025.
  • Vesting of 33,333 Restricted Stock Units on April 25, 2025.
  • Vesting of 33,333 shares of restricted stock on April 25, 2026.
  • Vesting of 33,333 Restricted Stock Units on April 25, 2026.
  • Vesting of 23,900 Restricted Stock Units on September 23, 2026.
  • Vesting of 33,334 shares of restricted stock on April 25, 2027.
  • Vesting of 33,334 Restricted Stock Units on April 25, 2027.
  • Vesting of 23,900 Restricted Stock Units on September 23, 2027.
  • Vesting of 23,899 Restricted Stock Units on September 23, 2028.
  • Expiration of Stock Appreciation Rights on November 14, 2032.

Key Dates

DateDescription
11/14/20236,667 Stock Appreciation Rights vested.
11/14/20246,667 Stock Appreciation Rights vested.
04/25/202533,333 Restricted Stock Units vest (from the 66,667 RSU grant).
09/23/2025Acquisition date for 71,699 Restricted Stock Units.
11/14/20256,666 Stock Appreciation Rights vest.
04/25/202633,333 shares of restricted stock vest (from the 119,168 common stock total); 33,333 Restricted Stock Units vest (from the 66,667 RSU grant).
09/23/202623,900 Restricted Stock Units vest (from the 71,699 RSU grant).
04/25/202733,334 shares of restricted stock vest (from the 119,168 common stock total); 33,334 Restricted Stock Units vest (from the 66,667 RSU grant).
09/23/202723,900 Restricted Stock Units vest (from the 71,699 RSU grant).
09/23/202823,899 Restricted Stock Units vest (from the 71,699 RSU grant).
11/14/2032Expiration date for Stock Appreciation Rights.

Keywords

Cineverse, CNVS, Form 4, insider transaction, beneficial ownership, restricted stock units, stock appreciation rights, executive compensation, equity awards

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.